Back to FRANKLIN TEMPLETON INC

AZN

2 quarters

Position history for FRANKLIN TEMPLETON INC's holdings in ASTRAZENECA PLC

Yes. Franklin Templeton holds 16,511,727 shares of AZN (AstraZeneca), worth $3.1B, as of its Q2 2026 13F filing. It reduced the position by 1,280,434 shares (-7.2%) from Q1 2026. Franklin Templeton has held AZN in every 13F on record since Q1 2026, 2 quarterly filings. AZN is 0.7% of Franklin Templeton's reported 13F portfolio.

Other major holders of AZN: VANGUARD CAPITAL MANAGEMENT LLC, Capital International Investors, NORGES BANK